Mill Creek Life Sciences

Mill Creek Life Sciences

Private
Rochester, MinnesotaHealthcare & Life Scienceshttps://millcreekls.com/

Last Round

Grant

Jun 18, 2019

Total Funding Raised

$3.8M

Momentum Score

75 /100

Company Overview

Mill Creek Life Sciences is a life sciences company that provides tools and technologies, such as human platelet lysates, to support the development and application of cellular and biologic therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

human platelet lysatehPLcell culture mediaFBS alternativexeno-free mediacellular therapyregenerative medicinecell expansionGMP grade reagentsancillary materialscritical reagentsserum-free mediaMSC expansionT-cell expansiontissue engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mill Creek Life Sciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mill Creek Life Sciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJun 18, 2019
GrantOct 8, 2018
GrantMay 1, 2015

Key People

Founding team and executive leadership

Bill Mirsch

CEO

Executive Team

Mill Creek Life Sciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 6, 2025

    Monthly visitors grew 491% MoM, reaching 999.

  • May 2, 2025

    Monthly visitors increased 83% MoM.

Mill Creek Life Sciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mill Creek Life Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mill Creek Life Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersRochester, Minnesota
Employee Range10
Year Founded2010
Last FundingJun 18, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.